Director, Informatics Reynald Lescarbeau discusses our first publication, which was in @CellReports, as his #RoadtotheClinic experience. The data in this manuscript validated the potential of our lipid nanoparticle platform, the foundation of NTLA-2001 and our in vivo pipeline. https://t.co/a5JKnw7ceh